Table 1.
Patients’ characteristics
|
Characteristics |
|
Sample population |
|---|---|---|
| N | Number (%) | median(range) |
| Age |
|
58 (53–68) |
| T stage |
|
|
| T1 |
5 |
|
| T2 |
24 |
|
| T3/4 |
1 |
|
| Grade |
|
|
| G1 |
9 |
|
| G2 |
14 |
|
| G3 |
7 |
|
| Sentinal node byopsy |
|
|
| Yes |
26 |
|
| No |
4 |
|
| Lymphadenectomy |
|
|
| Yes |
10 |
|
| No |
20 |
|
| Lymphnode status* |
|
|
| N0 |
21 |
|
| N1 |
9 |
|
| Histology |
|
|
| Classic |
23 |
|
| Basaloid |
6 |
|
| Verroucous |
1 |
|
| Corpus spongiosum infiltration |
|
|
| Yes |
18 |
|
| No |
12 |
|
| Corpora cavernosa infiltration |
|
|
| Yes |
7 |
|
| No |
23 |
|
| Uretrha infiltration |
|
|
| Yes |
1 |
|
| No |
29 |
|
| Lymphovascular invasion |
|
|
| Yes |
10 |
|
| No |
20 |
|
| Surgical operation |
|
|
| Local excision |
3 |
|
| Glansectomy |
1 |
|
| Partial penectomy |
11 |
|
| Total penectomy |
15 |
|
| High grade HPV status |
|
|
| Positive |
8 |
|
| Negative |
22 |
|
| p-EGFR status |
|
|
| Nuclear |
|
|
| Positive |
13 |
|
| Negative |
17 |
|
| Cytosolic |
|
|
| Positive |
16 |
|
| Negative |
14 |
|
| EGFR amplification status |
|
|
| Amplified |
0 |
|
| Aneuploid |
8 |
|
| Euploid |
17 |
|
| Not evaluated | 5 |
*As assessed by sentinal node biopsy and/or lymphadneectomy.